Pilot Study on Reducose Shows Potential to Improve Glycemic Control in Obese Youth
A pilot study is evaluating the effects of Reducose on glycemic and insulinemic levels in obese children and adolescents over 12 weeks.
Asset / Drug
Drug and asset intelligence for Reducose with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.